A Prospective Randomized Trial Comparing the 1-Stage with the 2-Stage Implantation of a Pulse Generator in Patients with Pelvic Floor Dysfunction Selected for Sacral Nerve Stimulation

European Urology

Volumn 45, Issue 5, 2004, Pages 649-654

  Everaert, K ^a   Kerckhaert, W ^a   Caluwaerts, H ^a   Audenaert, M ^a   Vereecke, H ^a   De Cuypere, G ^a   Boelaert, A ^a   Van Den Hombergh, U ^b   Oosterlinck, W ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b Medtronic InterStim   (Switzerland)

Author keywords

Incontinence; Lower urinary tract symptoms; Neuromodulation; Pelvic floor; Sacral nerve stimulation; Urinary retention; Voiding dysfunction

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; FOLLOW UP; HUMAN; IMPLANTATION; LOGISTIC REGRESSION ANALYSIS; MICTURITION DISORDER; NERVE STIMULATION; PELVIS FLOOR; PELVIS FLOOR DYSFUNCTION; PRIORITY JOURNAL; PULSE GENERATOR; RANDOMIZED CONTROLLED TRIAL; RESIDUAL URINE; SACRUM; TREATMENT FAILURE; URINALYSIS; URINE VOLUME; VISUAL ANALOG SCALE;

ALGORITHMS; COSTS AND COST ANALYSIS; ELECTRIC STIMULATION THERAPY; FOLLOW-UP STUDIES; HUMANS; LUMBOSACRAL PLEXUS; MIDDLE AGED; PELVIC FLOOR; PILOT PROJECTS; PROSPECTIVE STUDIES; URINATION DISORDERS;

EID: 1842788013     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2003.11.015     Document Type: Article

References (22)

1. Schmidt R.A., Senn E.S., Tanagho E.A. Functional evaluation of sacral root integrity. Report of a technique. Urol. 35:1990;388-392.
2. Thon W.F., Baskin L.S., Jonas U., Tanagho E.A., Schmidt R.A. Neuromodulation of voiding dysfunction and pelvic pain. World J. Urol. 9:1991;138-141.
3. Siegel S.W. Management of voiding dysfunction with an implantable neuroprosthesis. Urol. Clin. North Amer. 19:1992;163-170.
4. Bosch J.L., Groen J. Neuromodulation: urodynamic effects of sacral (S3) spinal nerve stimulation in patients with detrusor instability or detrusor hypereflexia. Behav. Brain Res. 92:1998;141-150.
5. Everaert K., De Ridder D., Baert L., Oosterlinck W., Wyndaele J.J. Patient satisfaction and complications following sacral nerve stimulation for urinary retention, urge incontinence and perineal pain: a multicenter evaluation. Int. Urogynecol. J. Pelvic Floor Dysf. 11:2000;231-235.
6. Janknegt R.A., Hassouna M.M., Siegel S.W., Schmidt R.A., Gajewski J.B., Rivas D.A.et al. Long-term effectiveness of sacral nerve stimulation for refractory urge incontinence. Eur. Urol. 39:2001;101-106.
7. Siegel S.W., Catanzaro F., Dijkema H.E., Elhilali M.M., Fowler C.J., Gajewski J.B.et al. Long-term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence, urgency-frequency, and retention. Urol. 56:2000;87-91.
8. Everaert K., Plancke H., Lefevere F., Oosterlinck W. The urodynamic evaluation of neuromodulation in patients with voiding dysfunction. Br. J. Urol. 79:1997;702-707.
9. Everaert K., Devulder J., De Muynck M., Stockman S., Depaepe H., De Looze D.et al. The pain cycle: implications for the diagnosis and treatment of pelvic pain syndromes. Int. Urogynecol. J. Pelvic Floor Dysf. 12:2001;9-14.
10. Hassouna M.M., Siegel S.W., Nyeholt A.A., Elhilali M.M., van Kerrebroeck P.E., Das A.K.et al. Sacral neuromodulation in the treatment of urgency-frequency symptoms: a multicenter study on efficacy and safety. J. Urol. 163:2000;1849-1854.
11. Aboseif S., Tamaddon K., Chalfin S., Freedman S., Kaptein J. Sacral neuromodulation as an effective treatment for refractory pelvic floor dysfunction. Urol. 60:2002;52-56.
12. Koldewijn E.L., Rosier P.F., Meuleman E.J., Koster A.M., Debruyne F.M., van Kerrebroeck P.E. Predictors of success with neuromodulation in lower urinary tract dysfunction: results of trial stimulation in 100 patients. J. Urol. 152:1994;2071-2075.
13. Janknegt R.A., Weil E.H.J., Eerdmans P.H. Improving neuromodulation technique for refractory voiding dysfunction: two-stage implant. Urol. 78:1997;39-46.
14. Scheepens W.A., Weil E.H., van Koeveringe G.A., Rohrmann D., Hedlun H.E., Schurch B.et al. Buttock placement of the implantable pulse generator: a new implantation technique for sacral neuromodulation - a multicentre study. Eur. Urol. 40:2001;434-438.
15. Standl T., Burmeister M.A., Hempel V. Is spinal anaesthesia for operations in the prone or jack-knife position suitable? Anaesthesist. 48:1999;242-250.
16. Stevens J.B., Wheatley L. Tracheal intubation in ambulatory surgery patients: using remifentanil and propofol without muscle relaxants. Anesth. Analg. 86:1998;45-49.
17. Erhan E., Ugur G., Gunusen I., Alper I., Ozyar B. Propofol - not thiopental or etomidate - with remifentanil provides adequate intubating conditions in the absence of neuromuscular blockade. Can. J. Anaesth. 50:2003;108-115.
18. Scheepens W.A., Van Koeveringe G.A., De Bie R.A., Weil E.H., Van Kerrebroeck P.E. Long-term efficacy and safety results of the two-stage implantation technique in sacral neuromodulation. BJU Int. 90:2002;840-845.
19. Comiter C.V. Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: a prospective study. J. Urol. 169:2003;1369-1373.
20. Kiss G., Rehder P., Maderspacher H. Modified PNE-testing with permanent electrodes gives better results. Eur. Urol Suppl. 1(1):2002;143. [Abstract 562].
21. Spinelli M., Giardiello G., Arduini A., van den Hombergh U. New percutaneous technique of sacral nerve stimulation has high initial success rate: preliminary results. Eur. Urol. 43:2003;70-74.
22. Spitzer R.L., Kroenke K., Williams J.B. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care evaluation of mental disorders. Patient Health Questionnaire. JAMA. 282:1999;1737-1744.